Third, enhanced early detection strategies, including improved awareness among healthcare providers about hepatoblastoma presentations and the use of alpha‐fetoprotein (AFP) screening in high‐risk populations, have facilitated earlier diagnosis and treatment initiation. This evidence concerns the gene AFP and hepatoblastoma.